Besides, treatment of human PASMCs with PDGF‐BB, to explore the PAH signaling, exhibited ERK and NF‐κB activation, enhanced NOX4 activity, and reactive oxygen species production. The gene discussed is NFKB1; the disease is pulmonary arterial hypertension.